Elite Pharmaceuticals, Inc. Proceeds from Other Debt
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from Other Debt of -$1.20 million for the 12-month period ending 2021-03-31, per its 10-K filed 2022-06-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherDebt · last filed 2022-06-29
- Elite Pharmaceuticals, Inc. proceeds from other debt for the quarter ending 2021-03-31 was -$2.21M.
- Elite Pharmaceuticals, Inc. proceeds from other debt for the quarter ending 2020-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from other debt for the quarter ending 2020-09-30 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from other debt for the quarter ending 2020-06-30 was $1.01M.
- Elite Pharmaceuticals, Inc. proceeds from other debt for fiscal 2021 was -$1.20M.
| Period end | Proceeds from Other Debt 3 month | Proceeds from Other Debt 6 month | Proceeds from Other Debt 9 month | Proceeds from Other Debt 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29 | -$2.21M derived: sum of 2 quarters · filed 2022-06-29 | -$2.21M derived: sum of 3 quarters · filed 2022-06-29 | -$1.20M 10-K · filed 2022-06-29 |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $1.01M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-16 | $1.01M 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $1.01M 10-Q · filed 2020-08-14 |